Yosuke Tsukiboshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yosuke Tsukiboshi has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Hiroki Yoshioka
Department of Hygiene Kitasato University School of Medicine Sagamihara Japan
7 shared publications - Kenichi Ogata
Kyushu University, Japan
6 shared publications - Hanane Horita
Gifu University of Medical Science, Japan
5 shared publications - Aya Ogata
Gifu University of Medical Science, Japan
4 shared publications - Hisaka Kurita
Laboratory of Medical Therapeutics and Molecular Therapeutics, Gifu Pharmaceutical University, 1-25-4 Daigaku-Nishi, Gifu 501-1196, Japan
4 shared publications - Hyogo Horiguchi
Department of Hygiene, Kitasato University School of Medicine, Sagamihara 252-0374, Japan
3 shared publications
Latest Publications
- 27 October 2026
- Published by Wiley in Dental Traumatology
A Fully In‐House Digital Workflow for Static Guided Endodontic Access in Post‐Traumatic Pulp Canal Obliteration
Pulp canal obliteration is a recognized sequela of traumatic dental injury and may represent a reparative pulpal response. Although pulp canal obliteration itself does not indicate endodontic treatment, pulp necrosis and apical periodontitis may subsequently develop, creating a technically challenging access problem in severely obliterated canals. Static guided endodontics provides a means of transferring a virtually planned access trajectory to the clinical setting. This article reviews the biological and clinical considerations of post‐traumatic pulp canal obliteration and the development of static guided endodontics, and describes a fully in‐house digital workflow integrating commercially available dental design applications with general‐purpose three‐dimensional mesh‐editing software. The workflow is clinically illustrated in a 57‐year‐old woman with a maxillary right central incisor (Tooth 11) showing post‐traumatic pulp canal obliteration, pulp necrosis, asymptomatic apical periodontitis, and crown discoloration approximately 50 years after the original injury. The geometry of the actual small‐diameter endodontic bur was directly measured and reproduced virtually for patient‐specific trajectory and guide design. Two sequential guides were fabricated in‐house and used to access the residual canal, followed by root canal treatment and internal bleaching. This approach illustrates how established digital concepts can be integrated into a clinician‐directed, fully in‐house workflow for managing technically challenging endodontic access in post‐traumatic pulp canal obliteration.
- 27 October 2026
- Published by Wiley in Dental Traumatology
A Fully In‐House Digital Workflow for Static Guided Endodontic Access in Post‐Traumatic Pulp Canal Obliteration
Pulp canal obliteration is a recognized sequela of traumatic dental injury and may represent a reparative pulpal response. Although pulp canal obliteration itself does not indicate endodontic treatment, pulp necrosis and apical periodontitis may subsequently develop, creating a technically challenging access problem in severely obliterated canals. Static guided endodontics provides a means of transferring a virtually planned access trajectory to the clinical setting. This article reviews the biological and clinical considerations of post‐traumatic pulp canal obliteration and the development of static guided endodontics, and describes a fully in‐house digital workflow integrating commercially available dental design applications with general‐purpose three‐dimensional mesh‐editing software. The workflow is clinically illustrated in a 57‐year‐old woman with a maxillary right central incisor (Tooth 11) showing post‐traumatic pulp canal obliteration, pulp necrosis, asymptomatic apical periodontitis, and crown discoloration approximately 50 years after the original injury. The geometry of the actual small‐diameter endodontic bur was directly measured and reproduced virtually for patient‐specific trajectory and guide design. Two sequential guides were fabricated in‐house and used to access the residual canal, followed by root canal treatment and internal bleaching. This approach illustrates how established digital concepts can be integrated into a clinician‐directed, fully in‐house workflow for managing technically challenging endodontic access in post‐traumatic pulp canal obliteration.
- Open Access
- 31 January 2026
- Published by Biomedical Research Press in Biomedical Research
- Vol. 47 (1) , 1-10
Perfluorohexanesulfonic acid-induced inhibition of human palate cell proliferation through upregulation of miR-374a-5p
Per- and poly fluoroalkyl substances (PFAS) pose significant global health risks. Although the use of classical PFAS such as perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) is regulated, the toxicological effects of alternative PFASs remain unknown. Cleft palate is a congenital condition influenced by both environmental and genetic factors. Although PFOS has been linked to cleft palate, the effects of other PFAS compounds remain unexplored. The aim of this study was to clarify the involvement of classical and alternative PFAS (PFHxA and PFHxS) in human embryonic palatal mesenchymal cell (HEPM) proliferation. Following PFAS treatment for 48 h, cell viability, apoptosis, and expression of cell cycle-related proteins were tested. In addition, miRNA levels and predicted target genes were measured, and a rescue experiment against PFHxS was conducted using an miR-374a-5p inhibitor. Among the four PFASs, PFHxS decreased the number of cells showing cyclin- and cyclin-dependent kinase reduction. In addition, PFHxS treatment upregulated miR-374a-5p and downregulated its downstream genes. Furthermore, miR- 374a-5p inhibitor alleviated the PFHxS-induced reduction in cell proliferation. These findings therefore indicate that miR-374a-5p plays a key role in the development of PFHxS-induced cleft palate and that alternative PFAS may have a highly toxic effect on HEPM cells.
- 31 January 2026
- Published by Biomedical Research Press in Biomedical Research
- Vol. 47 (1) , 1-10
Open AccessPerfluorohexanesulfonic acid-induced inhibition of human palate cell proliferation through upregulation of miR-374a-5p
Per- and poly fluoroalkyl substances (PFAS) pose significant global health risks. Although the use of classical PFAS such as perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) is regulated, the toxicological effects of alternative PFASs remain unknown. Cleft palate is a congenital condition influenced by both environmental and genetic factors. Although PFOS has been linked to cleft palate, the effects of other PFAS compounds remain unexplored. The aim of this study was to clarify the involvement of classical and alternative PFAS (PFHxA and PFHxS) in human embryonic palatal mesenchymal cell (HEPM) proliferation. Following PFAS treatment for 48 h, cell viability, apoptosis, and expression of cell cycle-related proteins were tested. In addition, miRNA levels and predicted target genes were measured, and a rescue experiment against PFHxS was conducted using an miR-374a-5p inhibitor. Among the four PFASs, PFHxS decreased the number of cells showing cyclin- and cyclin-dependent kinase reduction. In addition, PFHxS treatment upregulated miR-374a-5p and downregulated its downstream genes. Furthermore, miR- 374a-5p inhibitor alleviated the PFHxS-induced reduction in cell proliferation. These findings therefore indicate that miR-374a-5p plays a key role in the development of PFHxS-induced cleft palate and that alternative PFAS may have a highly toxic effect on HEPM cells.
- Open Access
- 21 August 2025
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (2) , 428-434
Digitally guided corticotomy using a customized surgical template (Suya corticotomy utility template): A technique report
Background: Precise control of corticotomy lines is critical in surgically facilitated orthodontic therapy. The Suya method is traditionally performed freehand, which introduces risks of root damage and procedural inconsistency. A digitally guided protocol may address these limitations by enhancing safety and technical predictability. Methods: A digital workflow based on the Suya method was developed using cone‐beam computed tomography (CBCT) and intraoral scanning data to generate a three‐dimensional (3D) integrated model of the maxilla. Vertical and apical osteotomy lines were virtually planned between roots and in the apical region. A customized surgical template (Suya corticotomy utility template) was designed using free software and fabricated via 3D printing. Guided corticotomy was performed using a piezoelectric device, followed by controlled chisel application along both vertical and apical cuts. Results: In a 32‐year‐old female patient, the digitally guided corticotomy was executed with high accuracy and reproducibility. Piezoelectric cortical incisions followed the preplanned paths without deviation. Chisel application along the guide‐defined paths resulted in controlled fracturization. Postoperative CBCT confirmed that all osteotomies were positioned safely between roots, with no evidence of root contact or damage. Conclusions: This digitally guided Suya method provides a reproducible and biologically sound approach for performing root‐sensitive corticotomy with enhanced surgical control. The use of 3D‐printed guides tailored to piezoelectric instrumentation may improve safety, accuracy, and standardization of corticotomy procedures in interdisciplinary periodontal care. Key points: A digitally guided corticotomy protocol based on the Suya method enables root‐sensitive osteotomy with improved surgical accuracy and safety. CBCT and IOS integration allows for precise virtual planning of osteotomy lines, which can be transferred intraoperatively using a customized 3D‐printed guide (Suya corticotomy utility template). The workflow supports reproducible corticotomy in adult patients with dense cortical bone, minimizing the risk of root damage and surgical variability. Plain language summary: Orthodontic treatments in adults can take a long time due to slower bone remodeling. To speed this up, surgeons may perform a procedure called corticotomy, where small cuts are made in the bone around the teeth to stimulate faster movement. However, doing this by hand can be tricky and risky, especially near tooth roots and nerves. In this report, we describe a new method that uses digital planning and a custom‐made surgical guide (called the Suya corticotomy utility template) to help perform these bone cuts with much more precision. The guide is created by combining three‐dimensional (3D) images from dental scans and carefully planning the cutting paths in a computer program. We then 3D‐print the guide and use it during surgery to safely direct the surgical instruments. In the case we present, the procedure went smoothly, and post‐surgery scans showed no damage to the teeth. This approach may make the procedure safer and more predictable for patients, especially in complex orthodontic cases.
- 21 August 2025
- Published by Wiley in Clinical Advances in Periodontics
- Vol. 16 (2) , 428-434
Open AccessDigitally guided corticotomy using a customized surgical template (Suya corticotomy utility template): A technique report
Background: Precise control of corticotomy lines is critical in surgically facilitated orthodontic therapy. The Suya method is traditionally performed freehand, which introduces risks of root damage and procedural inconsistency. A digitally guided protocol may address these limitations by enhancing safety and technical predictability. Methods: A digital workflow based on the Suya method was developed using cone‐beam computed tomography (CBCT) and intraoral scanning data to generate a three‐dimensional (3D) integrated model of the maxilla. Vertical and apical osteotomy lines were virtually planned between roots and in the apical region. A customized surgical template (Suya corticotomy utility template) was designed using free software and fabricated via 3D printing. Guided corticotomy was performed using a piezoelectric device, followed by controlled chisel application along both vertical and apical cuts. Results: In a 32‐year‐old female patient, the digitally guided corticotomy was executed with high accuracy and reproducibility. Piezoelectric cortical incisions followed the preplanned paths without deviation. Chisel application along the guide‐defined paths resulted in controlled fracturization. Postoperative CBCT confirmed that all osteotomies were positioned safely between roots, with no evidence of root contact or damage. Conclusions: This digitally guided Suya method provides a reproducible and biologically sound approach for performing root‐sensitive corticotomy with enhanced surgical control. The use of 3D‐printed guides tailored to piezoelectric instrumentation may improve safety, accuracy, and standardization of corticotomy procedures in interdisciplinary periodontal care. Key points: A digitally guided corticotomy protocol based on the Suya method enables root‐sensitive osteotomy with improved surgical accuracy and safety. CBCT and IOS integration allows for precise virtual planning of osteotomy lines, which can be transferred intraoperatively using a customized 3D‐printed guide (Suya corticotomy utility template). The workflow supports reproducible corticotomy in adult patients with dense cortical bone, minimizing the risk of root damage and surgical variability. Plain language summary: Orthodontic treatments in adults can take a long time due to slower bone remodeling. To speed this up, surgeons may perform a procedure called corticotomy, where small cuts are made in the bone around the teeth to stimulate faster movement. However, doing this by hand can be tricky and risky, especially near tooth roots and nerves. In this report, we describe a new method that uses digital planning and a custom‐made surgical guide (called the Suya corticotomy utility template) to help perform these bone cuts with much more precision. The guide is created by combining three‐dimensional (3D) images from dental scans and carefully planning the cutting paths in a computer program. We then 3D‐print the guide and use it during surgery to safely direct the surgical instruments. In the case we present, the procedure went smoothly, and post‐surgery scans showed no damage to the teeth. This approach may make the procedure safer and more predictable for patients, especially in complex orthodontic cases.
- Open Access
- 10 August 2025
- Published by Wiley in Journal of Periodontology
- Vol. 97 (2) , 220-233
Volumetric buccal bone alterations at immediate implant sites with or without soft tissue augmentation: A 6‐month assessment
Background: This study is part of a randomized controlled trial investigating the impact of soft tissue augmentation (STA) using subepithelial connective tissue graft (SCTG) (immediate implant with subepithelial connective tissue graft [ICT] group) or acellular dermal matrix (ADM) (immediate implant with acellular dermal matrix [IAD] group) versus no STA (control) on the clinical outcomes following immediate implant placement (IIP). This study aimed to investigate volumetric buccal bone dimensional changes at immediate implant sites 6 months after the surgery. Methods: Forty‐five patients requiring extraction of a maxillary anterior tooth or premolar and randomly assigned to one of the three groups were included. Cone‐beam computed tomography (CBCT) images were obtained prior to tooth extraction and 6 months after IIP and then superimposed to evaluate 3D (volumetric) and 2D (linear) changes in buccal bone dimensions around the implant. Measurements included three regions of interest (coronal, middle, and apical segments). The associations between clinical factors and 3D buccal bone dimensional changes were analyzed using linear regression analysis. The correlations between 3D and 2D measurements were analyzed using Pearson's correlation coefficient. Statistical significance was assessed using an alpha level of 0.05. Results: Volumetric bone dimensional changes were not significantly different between the groups. The greatest amount of bone loss occurred in the coronal segment (ICT: −14.99 ± 4.29 mm 3 ; IAD: −13.60 ± 3.97 mm 3 ; Control: −12.58 ± 4.09 mm 3 ; p = 0.286). The thick bone morphotype was significantly associated with increased absolute volumetric bone loss ( p = 0.001, 0.041, and 0.013 for coronal, middle, and apical segments, respectively). Measurements of 3D and 2D bone dimensional changes had low to high correlations (range 0.39–0.95) in different segments. Conclusion: STA did not significantly affect bone dimensional loss at 6 months. Linear measurements may not fully represent volumetric bone dimensional changes at immediate implant sites. Clinical trial registration: This study is part of a randomized controlled trial (RCT) registered with ClinicalTrials.gov (ID NCT02864862). The title of the trial is Esthetic Outcomes Following Immediate Implant Combined with Soft Tissue Augmentation . Plain language summary: This study investigated how soft tissue augmentation (STA) affected the changes in bone around dental implants placed immediately after tooth extraction. Specifically, it compared the use of a connective tissue graft and an acellular dermal matrix against no STA. Forty‐five patients who needed a maxillary anterior tooth or premolar extraction and a dental implant were included. Before the extraction and 6 months after implant placement, cone‐beam computed tomography (CBCT) scans were taken to measure changes in the bone dimensions around the implants. The analysis included three sections of the bone: the coronal, middle, and apical sections. The results showed no significant differences in bone changes between the different treatment groups. The greatest bone loss was found in the coronal section. Measurements taken in three dimensions (3D) and two dimensions (2D) showed varying degrees of correlation. Overall, the findings suggested that STA did not affect bone loss around dental implants, and 2D measurements may not accurately reflect the 3D changes in bone.
- 10 August 2025
- Published by Wiley in Journal of Periodontology
- Vol. 97 (2) , 220-233
Open AccessVolumetric buccal bone alterations at immediate implant sites with or without soft tissue augmentation: A 6‐month assessment
Background: This study is part of a randomized controlled trial investigating the impact of soft tissue augmentation (STA) using subepithelial connective tissue graft (SCTG) (immediate implant with subepithelial connective tissue graft [ICT] group) or acellular dermal matrix (ADM) (immediate implant with acellular dermal matrix [IAD] group) versus no STA (control) on the clinical outcomes following immediate implant placement (IIP). This study aimed to investigate volumetric buccal bone dimensional changes at immediate implant sites 6 months after the surgery. Methods: Forty‐five patients requiring extraction of a maxillary anterior tooth or premolar and randomly assigned to one of the three groups were included. Cone‐beam computed tomography (CBCT) images were obtained prior to tooth extraction and 6 months after IIP and then superimposed to evaluate 3D (volumetric) and 2D (linear) changes in buccal bone dimensions around the implant. Measurements included three regions of interest (coronal, middle, and apical segments). The associations between clinical factors and 3D buccal bone dimensional changes were analyzed using linear regression analysis. The correlations between 3D and 2D measurements were analyzed using Pearson's correlation coefficient. Statistical significance was assessed using an alpha level of 0.05. Results: Volumetric bone dimensional changes were not significantly different between the groups. The greatest amount of bone loss occurred in the coronal segment (ICT: −14.99 ± 4.29 mm 3 ; IAD: −13.60 ± 3.97 mm 3 ; Control: −12.58 ± 4.09 mm 3 ; p = 0.286). The thick bone morphotype was significantly associated with increased absolute volumetric bone loss ( p = 0.001, 0.041, and 0.013 for coronal, middle, and apical segments, respectively). Measurements of 3D and 2D bone dimensional changes had low to high correlations (range 0.39–0.95) in different segments. Conclusion: STA did not significantly affect bone dimensional loss at 6 months. Linear measurements may not fully represent volumetric bone dimensional changes at immediate implant sites. Clinical trial registration: This study is part of a randomized controlled trial (RCT) registered with ClinicalTrials.gov (ID NCT02864862). The title of the trial is Esthetic Outcomes Following Immediate Implant Combined with Soft Tissue Augmentation . Plain language summary: This study investigated how soft tissue augmentation (STA) affected the changes in bone around dental implants placed immediately after tooth extraction. Specifically, it compared the use of a connective tissue graft and an acellular dermal matrix against no STA. Forty‐five patients who needed a maxillary anterior tooth or premolar extraction and a dental implant were included. Before the extraction and 6 months after implant placement, cone‐beam computed tomography (CBCT) scans were taken to measure changes in the bone dimensions around the implants. The analysis included three sections of the bone: the coronal, middle, and apical sections. The results showed no significant differences in bone changes between the different treatment groups. The greatest bone loss was found in the coronal section. Measurements taken in three dimensions (3D) and two dimensions (2D) showed varying degrees of correlation. Overall, the findings suggested that STA did not affect bone loss around dental implants, and 2D measurements may not accurately reflect the 3D changes in bone.
- Open Access
- 15 May 2025
- Published by MDPI AG in Preprints.org
Perfluorohexanoic Acid-Induced Inhibition of Human Palate Cell Proliferation Through Upregulation of miR-374a-5p
Per- and poly fluoroalkyl substances (PFAS) pose serious health concerns worldwide. Although the use of classical PFAS, such as perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA), is regulated, the toxicological effects of alternative PFASs remain unknown. Cleft palate is a birth defect that is associated with environmental and genetic factors. Although an association between PFOS-induced and cleft palate has been reported, whether alternative PFASs affect cleft palate remains to be fully elucidated. The aim of this study was to clarify the involvement of classical and alternative PFAS (PFHxA and PFHxS) in the proliferation of human embryonic palatal mesenchymal cells (HEPM). Cell viability, apoptosis, and cell cycle-related markers were evaluated after PFASs treatment. In addition, miRNA levels and their downstream genes were measured, and a rescue experiment was performed using the miR-374a-5p inhibitor. Among the four PFASs, PFHxS decreased the number of cells with cyclin- and cyclin-dependent kinase reduction. In addition, PFHxS treatment upregulated miR-374a-5p and its downstream genes. Furthermore, miR-374a-5p inhibitor alleviated the PFHxS-induced inhibition of cell proliferation. These results suggest that PFHxS-induced cleft palate associated with miR-374a-5p and alternative PFAS may have a highly toxic effect on HEPM cells.
- 15 May 2025
- Published by MDPI AG in Preprints.org
Open AccessPerfluorohexanoic Acid-Induced Inhibition of Human Palate Cell Proliferation Through Upregulation of miR-374a-5p
Per- and poly fluoroalkyl substances (PFAS) pose serious health concerns worldwide. Although the use of classical PFAS, such as perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA), is regulated, the toxicological effects of alternative PFASs remain unknown. Cleft palate is a birth defect that is associated with environmental and genetic factors. Although an association between PFOS-induced and cleft palate has been reported, whether alternative PFASs affect cleft palate remains to be fully elucidated. The aim of this study was to clarify the involvement of classical and alternative PFAS (PFHxA and PFHxS) in the proliferation of human embryonic palatal mesenchymal cells (HEPM). Cell viability, apoptosis, and cell cycle-related markers were evaluated after PFASs treatment. In addition, miRNA levels and their downstream genes were measured, and a rescue experiment was performed using the miR-374a-5p inhibitor. Among the four PFASs, PFHxS decreased the number of cells with cyclin- and cyclin-dependent kinase reduction. In addition, PFHxS treatment upregulated miR-374a-5p and its downstream genes. Furthermore, miR-374a-5p inhibitor alleviated the PFHxS-induced inhibition of cell proliferation. These results suggest that PFHxS-induced cleft palate associated with miR-374a-5p and alternative PFAS may have a highly toxic effect on HEPM cells.
- Open Access
Sasa veitchii Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating microRNA-4680-3p
Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft palate. However, the research on MPM-induced cleft palate remains limited. Sasa veitchii extract (SE), a medical plant extract, is commercially available in Asia and has been reported to show effectiveness against oral diseases. The purpose of the present study is to evaluate whether SE protects against MPM-induced immunosuppression in human embryonic palatal mesenchymal (HEPM) cells. Cell viability and G1 phase-related cell cycle markers were assessed by co-treatment with MPM and SE. Furthermore, we quantified cleft palate-associated miRNA levels and the expression of its downstream genes. MPM treatment reduced cell viability in a concentration-dependent manner. Co-treatment with SE alleviated MPM-induced inhibition of HEPM cell proliferation. Additionally, SE reduced MPM-induced miR-4680-3p upregulation and the downregulation of its downstream genes (ERBB2 and JADE1). These results suggest that SE alleviated MPM-induced cell proliferation inhibition through modulating miR-4680-3p expression.
Open AccessSasa veitchii Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating microRNA-4680-3p
Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft palate. However, the research on MPM-induced cleft palate remains limited. Sasa veitchii extract (SE), a medical plant extract, is commercially available in Asia and has been reported to show effectiveness against oral diseases. The purpose of the present study is to evaluate whether SE protects against MPM-induced immunosuppression in human embryonic palatal mesenchymal (HEPM) cells. Cell viability and G1 phase-related cell cycle markers were assessed by co-treatment with MPM and SE. Furthermore, we quantified cleft palate-associated miRNA levels and the expression of its downstream genes. MPM treatment reduced cell viability in a concentration-dependent manner. Co-treatment with SE alleviated MPM-induced inhibition of HEPM cell proliferation. Additionally, SE reduced MPM-induced miR-4680-3p upregulation and the downregulation of its downstream genes (ERBB2 and JADE1). These results suggest that SE alleviated MPM-induced cell proliferation inhibition through modulating miR-4680-3p expression.
- Open Access
- 11 March 2025
- Published by MDPI AG in Preprints.org
Sasa veitchii Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating microRNA-4680-3p
(1) Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft palate. However, the research on MPM-induced cleft palate remains limited. Sasa veitchii extract (SE), a medical plant extract, is commercially available in Asia and has been reported to show the effectiveness on oral diseases. The purpose of the present study is to evaluate whether SE protects against MPM-induced immunosuppression in human embryonic palatal mesenchymal (HEPM) cells. (2) Methods: Cell viability and G1 phase-related cell cycle markers were assessed by cotreatment with MPM and SE. Furthermore, we quantified cleft palate-associated miRNA levels and the expression of its downstream genes. (3) Results: MPM treatment reduced cell viability in a concentration-dependent manner. Co-treatment with SE alleviated MPM-induced inhibition of HEPM cell proliferation. Additionally, SE reduced MPM-induced miR-4680-3p upregulation and the downregulation of its downstream genes (ERBB2 and JADE1). (4) Conclusions: These results suggest that SE alleviated MPM-induced cell proliferation inhibition through modulating miR-4680-3p expression.
- 11 March 2025
- Published by MDPI AG in Preprints.org
Open AccessSasa veitchii Extract Mitigates Mycophenolate Mofetil-Induced Human Palatal Cell Proliferation Inhibition by Downregulating microRNA-4680-3p
(1) Cleft palate is a common birth defect worldwide and is caused by both genetic and environmental factors. Intrauterine drug exposure is one of the environmental factors that can induce cleft palate. Mycophenolate mofetil (MPM) is an immunosuppressant drug with teratogenic effects, including cleft palate. However, the research on MPM-induced cleft palate remains limited. Sasa veitchii extract (SE), a medical plant extract, is commercially available in Asia and has been reported to show the effectiveness on oral diseases. The purpose of the present study is to evaluate whether SE protects against MPM-induced immunosuppression in human embryonic palatal mesenchymal (HEPM) cells. (2) Methods: Cell viability and G1 phase-related cell cycle markers were assessed by cotreatment with MPM and SE. Furthermore, we quantified cleft palate-associated miRNA levels and the expression of its downstream genes. (3) Results: MPM treatment reduced cell viability in a concentration-dependent manner. Co-treatment with SE alleviated MPM-induced inhibition of HEPM cell proliferation. Additionally, SE reduced MPM-induced miR-4680-3p upregulation and the downregulation of its downstream genes (ERBB2 and JADE1). (4) Conclusions: These results suggest that SE alleviated MPM-induced cell proliferation inhibition through modulating miR-4680-3p expression.
- Open Access
- 6 February 2025
- Published by MDPI AG in Non-Coding RNA
- Vol. 11 (1) , 12
Cleft Palate Induced by Mycophenolate Mofetil Is Associated with miR-4680-3p and let-7c-5p in Human Palate Cells
Background/Objectives: Cleft palate is a birth defect associated with environmental and genetic factors. Disturbance of microRNAs (miRNAs) and exposure to medicinal agents during pregnancy can cause cleft palate. Although an association between medicine-induced cleft palate and miRNAs has been suggested, it remains to be fully elucidated. This study aimed to clarify the molecular mechanism underlying mycophenolate mofetil (MPM)-induced inhibition of cell proliferation and miRNA expression in human embryonic palatal mesenchymal (HEPM) cells. Methods: Cell viability, apoptosis, and cell cycle-related markers were evaluated 48 h after MPM treatment. In addition, miRNA levels and expression of their downstream genes were measured, and a rescue experiment was performed using miR-4680-3p and/or let-7c-5p inhibitors. Results: MPM dose-dependently reduced HEPM cell viability. Additionally, MPM treatment suppressed cyclin-D1, cyclin E1, cyclin-dependent kinase (CDK)-2, and CDK6 expression in HEPM cells. Furthermore, MPM upregulated miR-4680-3p and let-7c-5p expression and downregulated the downstream genes of each miRNA. Moreover, miR-4680-3p and/or let-7c-5p inhibitors alleviated MPM-induced inhibition of cell proliferation. Conclusions: These results suggest that MPM-induced cleft palate is associated with miR-4680-3p and let-7c-5p expression in HEPM cells.
- 6 February 2025
- Published by MDPI AG in Non-Coding RNA
- Vol. 11 (1) , 12
Open AccessCleft Palate Induced by Mycophenolate Mofetil Is Associated with miR-4680-3p and let-7c-5p in Human Palate Cells
Background/Objectives: Cleft palate is a birth defect associated with environmental and genetic factors. Disturbance of microRNAs (miRNAs) and exposure to medicinal agents during pregnancy can cause cleft palate. Although an association between medicine-induced cleft palate and miRNAs has been suggested, it remains to be fully elucidated. This study aimed to clarify the molecular mechanism underlying mycophenolate mofetil (MPM)-induced inhibition of cell proliferation and miRNA expression in human embryonic palatal mesenchymal (HEPM) cells. Methods: Cell viability, apoptosis, and cell cycle-related markers were evaluated 48 h after MPM treatment. In addition, miRNA levels and expression of their downstream genes were measured, and a rescue experiment was performed using miR-4680-3p and/or let-7c-5p inhibitors. Results: MPM dose-dependently reduced HEPM cell viability. Additionally, MPM treatment suppressed cyclin-D1, cyclin E1, cyclin-dependent kinase (CDK)-2, and CDK6 expression in HEPM cells. Furthermore, MPM upregulated miR-4680-3p and let-7c-5p expression and downregulated the downstream genes of each miRNA. Moreover, miR-4680-3p and/or let-7c-5p inhibitors alleviated MPM-induced inhibition of cell proliferation. Conclusions: These results suggest that MPM-induced cleft palate is associated with miR-4680-3p and let-7c-5p expression in HEPM cells.
- Open Access
- 8 January 2025
- Published by MDPI AG in Preprints.org
Cleft Palate Induced by Mycophenolate Mofetil Is Associated with miR-4680-3p and Let-7c-5p in Human Palate Cells
Background/Objectives: Cleft palate is a birth defect associated with environmental and genetic factors. It has been reported that disturbance of microRNAs (miRNAs) and exposure to medicinal agents during pregnancy can cause cleft palate. Although an association between medicine-induced cleft palate and miRNAs has been suggested, it remains to be fully elucidated. This study aimed to clarify the molecular mechanism underlying mycophenolate mofetil (MPM)-induced inhibition of cell proliferation and miRNA expression in human embryonic palatal mesenchymal (HEPM) cells. Methods: Cell viability, apoptosis, and cell cycle-related markers were evaluated 48 h after MPM treatment. In addition, miRNA levels and expression of their downstream genes were measured, and a rescue experiment was performed using miR-4680-3p and/or let-7c-5p inhibitors. Results: MPM dose-dependently reduced HEPM cell viability. Additionally, MPM treatment suppressed cyclin-D1, cyclin E1, cyclin-dependent kinase (CDK)-2, and CDK6 expression in HEPM cells. Furthermore, MPM upregulated miR-4680-3p and let-7c-5p expression and downregulated the downstream genes of each miRNA. Moreover, miR-4680-3p and/or let-7c-5p inhibitors alleviated MPM-induced inhibition of cell proliferation. Conclusions: These results suggest that MPM-induced cleft palate is associated with miR-4680-3p and let-7c-5p expression in HEPM cells.
- 8 January 2025
- Published by MDPI AG in Preprints.org
Open AccessCleft Palate Induced by Mycophenolate Mofetil Is Associated with miR-4680-3p and Let-7c-5p in Human Palate Cells
Background/Objectives: Cleft palate is a birth defect associated with environmental and genetic factors. It has been reported that disturbance of microRNAs (miRNAs) and exposure to medicinal agents during pregnancy can cause cleft palate. Although an association between medicine-induced cleft palate and miRNAs has been suggested, it remains to be fully elucidated. This study aimed to clarify the molecular mechanism underlying mycophenolate mofetil (MPM)-induced inhibition of cell proliferation and miRNA expression in human embryonic palatal mesenchymal (HEPM) cells. Methods: Cell viability, apoptosis, and cell cycle-related markers were evaluated 48 h after MPM treatment. In addition, miRNA levels and expression of their downstream genes were measured, and a rescue experiment was performed using miR-4680-3p and/or let-7c-5p inhibitors. Results: MPM dose-dependently reduced HEPM cell viability. Additionally, MPM treatment suppressed cyclin-D1, cyclin E1, cyclin-dependent kinase (CDK)-2, and CDK6 expression in HEPM cells. Furthermore, MPM upregulated miR-4680-3p and let-7c-5p expression and downregulated the downstream genes of each miRNA. Moreover, miR-4680-3p and/or let-7c-5p inhibitors alleviated MPM-induced inhibition of cell proliferation. Conclusions: These results suggest that MPM-induced cleft palate is associated with miR-4680-3p and let-7c-5p expression in HEPM cells.